RR6 Size:Contact [email protected] for quotation PROTACs: An Emerging Therapeutic Modality

PROTACs: An Emerging Therapeutic Modality in Precision Medicine

with IC50 of 434 nM compared to the enzymatic IC50 of 75 nM

E7766 diammonium salt is shown to have potent antitumor activity with long lasting immune memory response in a mouse liver metastatic tumor model

CAS Number: 1398046-21-3

RR6 Size:Contact [email protected] for quotation PROTACs: An Emerging Therapeutic ModalityRR6 is a potent, selective, reversible, competitive and orally active vanin inhibitor with an IC50 of 540 nM for recombinant vanin 1. RR6 also potently inhibits human, bovine and rat serum pantetheinase with IC50 values of 40 nM, 41 nM and 87 nM, respectively. Product information CAS Number: 1351758 37 6 Molecular Weight: 293. 36 Formula: C16H23NO4 Chemical Name: (2R) 2,4 dihydroxy 3,3 dimethyl N (3 oxo 4 phenylbutyl)butanamide Smiles: